Effects of Vitamin D Use on Outcomes of Psychotic Symptoms in Alzheimer Disease Patients
Alzheimer disease (AD) is the most common form of dementia (estimated to be 50% −60% of all cases) and the sixth most common cause of death in the United States with the absolute numbers growing,1 although its prevalence is decreasing.2 Today, only five drugs approved by the U.S. Food and Drug Administration are used to treat the cognitive dysfunction of AD, tacrine, donepezi l, rivastigmine, galantamine, and memantine. These drugs are modestly efficacious for cognitive abilities in early to moderate stages of AD.
Source: The American Journal of Geriatric Psychiatry - Category: Geriatrics Authors: Lirong Wang, Jian Ying, Peihao Fan, Elise A. Weamer, Mary Ann A. DeMichele-Sweet, Oscar L. Lopez, Julia K. Kofler, Robert A. Sweet Tags: Regular Research Article Source Type: research
More News: Alzheimer's | Dementia | Food and Drug Administration (FDA) | Geriatrics | Namenda | Psychiatry | USA Health | Vitamin D | Vitamins